Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ACTUATE THERAPEUTICS, INC. | Director | Non-Qualified Stock Options | 30K | Aug 12, 2024 | Direct | ||
Magenta Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 20K | Jun 28, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ACTU | ACTUATE THERAPEUTICS, INC. | Aug 12, 2024 | 1 | $0 | 4 | Aug 14, 2024 | Director |
ACTU | ACTUATE THERAPEUTICS, INC. | Aug 12, 2024 | 0 | $0 | 3 | Aug 14, 2024 | Director |
MGTA | Magenta Therapeutics, Inc. | Jun 28, 2022 | 1 | $0 | 4 | Jun 30, 2022 | Director |
MGTA | Magenta Therapeutics, Inc. | Jun 1, 2021 | 1 | $0 | 4 | Jun 3, 2021 | Director |